Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Cerebral deposition of amyloid beta peptide is an early and critical feature of Alzheimer's disease. Additionally we are shipping beta-Site APP-Cleaving Enzyme 1 Antibodies (230) and beta-Site APP-Cleaving Enzyme 1 Proteins (33) and many more products for this protein.
Showing 10 out of 71 products:
Lee, Park, Han: Effect of mycelial extract of Clavicorona pyxidata on the production of amyloid beta-peptide and the inhibition of endogenous beta-secretase activity in vitro. in Journal of microbiology (Seoul, Korea) 2007
Show all 3 Pubmed References
Human BACE ELISA Kit for Sandwich ELISA - ABIN1110850
Johnson, Drugan, Miller, Evans: 38 in 1991
Show all 2 Pubmed References
Human BACE ELISA Kit for Sandwich ELISA - ABIN365021
Qian, Ding, Cheng, Zhu, Zhao, Jin, Guan, Zhang, Chen, Xu: Early biomarkers for post-stroke cognitive impairment. in Journal of neurology 2012
Mouse (Murine) BACE ELISA Kit for Sandwich ELISA - ABIN424458
Che, Zhou, Zhang, Zhang, Ding, Yanagita, Xu, Xue, Wang: Comparative study of the effects of phosphatidylcholine rich in DHA and EPA on Alzheimer's disease and the possible mechanisms in CHO-APP/PS1 cells and SAMP8 mice. in Food & function 2017
Results indicated that the proinflammatory cytokine TNF-alpha impairs endothelial tight junctions and promotes monocyte-endothelial cell adhesion by upregulating beta-site amyloid precursor protein enzyme 1 expression through activating PKC signaling and sequentially cleaving alpha-2, 6-sialic acid transferase 1.
Study did not detect any difference in peripheral expression of BACE1 and its naturally occurring antisense in epileptic patients and healthy subjects but a significant correlation between the transcript levels of these genes.
BACE1 is predominantly SUMOylated at K501 residue, which escalates its protease activity and stability and subsequently increases Abeta (show APP ELISA Kits) production.
Their anti-BACE1 and antimicrobial activity.
Structural arrangement of BACE1-TM trimers and a mechanism for copper ion conduction that might also apply to other proteins involved in metal ion transport.
Potentials for beneficial or consequential effects resulting from pharmacologic inhibition of BACE1 are reviewed in context of ongoing clinical trials testing the effect of BACE1 candidate inhibitor drugs in Alzheimer's disease populations.
Measured plasma levels of beta-secretase 1 (BACE1) long non-coding RNA(LncRNA) in Alzheimer disease (AD) patients and healthy controls; found plasma BACE1 LncRNA to be a specific biomarker for AD.
Amyloid beta oligomers modulate BACE1 through an XBP-1 (show XBP1 ELISA Kits)-dependent pathway involving HRD1 (show SYVN1 ELISA Kits).
Polymethoxyflavones isolated from citrus peels might be considered as promising BACE1 inhibitory agents that could lower Abeta (show APP ELISA Kits) production in Alzheimer disease.
In BACE1 transgenic (Tg) mice, axonal regeneration was reduced when compared with wilde-type (WT) littermates at 3 and 10 days post crush. Study observed a decreased percentage of innervated neuromuscular junctions at 15 days post crush; and a functional recovery delay in the transgenic mice as it took 8 weeks for the compound muscle action potential amplitudes of Tg mice to begin to reach similar values comparable to WT.
we have demonstrated that raised hypothalamic Abeta1-42, in conjunction with HFD, is sufficient to induce leptin (show LEP ELISA Kits) resistance in the absence of increased inflammation, ER stress, SOCS3 (show SOCS3 ELISA Kits) and PTP1B (show PTPN1 ELISA Kits). Thus, counteracting raised Bace1 activity associated with chronic HFD will play a critical protective role against metabolic disease
BACE1 deficiency develops abnormal clusters of immature neurons, forming doublecortin (show DCX ELISA Kits)-positive neuroblasts, in the developing dentate gyrus, mainly in the subpial zone.
Increased TNFR1 (show TNFRSF1A ELISA Kits) expression and signaling in injured peripheral nerves of mice with reduced BACE1 activity
We aimed to explore the potential therapeutic effect of PGC-1alpha (show PPARGC1A ELISA Kits) by generating a lentiviral vector to express human PGC-1alpha (show PPARGC1A ELISA Kits) and target it by stereotaxic delivery to hippocampus and cortex of APP23 transgenic mice . Four months after hPGC-1alpha injection, mice showed improved spatial and recognition memory concomitant with a significant reduction in Abeta (show APP ELISA Kits) deposition, associated with a decrease in BACE1 expression
that BACE1 deficiency enhances proliferation of Schwann cell due to the elevated Jag1 (show JAG1 ELISA Kits)/Delta1-Notch (show NOTCH1 ELISA Kits) signaling
the synaptic localization of APP (show APP ELISA Kits), ADAM10 (show ADAM10 ELISA Kits), and BACE1 in the mouse cerebral cortex, was examined.
study demonstrates that SEZ6 and SEZ6L are physiological BACE1 substrates in the murine brain and suggests that sSEZ6 and sSEZ6L levels in CSF (show CSF2 ELISA Kits) are suitable markers to monitor BACE1 inhibition in mice
Chronic variable stress led to increased Bace1 expression in the hippocampus of young adult mice and the hippocampus, prefrontal cortex and amygdala of aged mice. The increased expression of Bace1 was associated with decreased methylation of several CpGs in the Bace1 promoter region.
Results indicate that SNX4-mediated regulation of the steady-state levels and trafficking of BACE1, as well as the subsequent increase in BACE1-mediated cleavage, may be relevant to Alzheimer's disease progression.
bace1 mutants display hypomyelination in the peripheral nervous system and supernumerary neuromasts while in bace2 (show BACE2 ELISA Kits) mutants the shape and migration of melanocytes is affected.
Cerebral deposition of amyloid beta peptide is an early and critical feature of Alzheimer's disease. Amyloid beta peptide is generated by proteolytic cleavage of amyloid precursor protein (APP) by two proteases, one of which is the protein encoded by this gene. The encoded protein, a member of the peptidase A1 protein family, is a type I integral membrane glycoprotein and aspartic protease that is found mainly in the Golgi. Multiple transcript variants encoding different isoforms have been described for this gene.
, asp 2
, aspartyl protease 2
, beta-secretase 1
, beta-secretase 1 precursor variant 1
, beta-site APP cleaving enzyme 1
, beta-site amyloid beta A4 precursor protein-cleaving enzyme
, membrane-associated aspartic protease 2
, transmembrane aspartic proteinase Asp2
, beta-site amyloid precursor protein cleaving enzyme 1
, beta-site APP cleaving enzyme
, beta secretase 1
, beta-secretase 1 isoform A preproprotein
, beta-secretase 1 isoform B preproprotein
, beta-secretase 1 isoform C preproprotein
, beta-site APP-cleaving enzyme 1
, beta-secretase 1-like